Power3 initiates validation study of NuroPro diagnostic test
The clinical validation study will be a blinded study of Power3’s NuroPro diagnostic test, which is a blood test for the detection of Alzheimer’s and Parkinson’s disease. The
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).